Patent · US Active

Crystalline forms of CFTR modulators

US11873300B2 · kind B2 · utility

4Cited by
19References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 13, 2020
Grant dateJan 16, 2024
Priority date—
Expiry dateAug 13, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Crystalline forms of Compound I: pharmaceutically acceptable salts thereof, and solvates and hydrates thereof are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.